7346-79-4

Usage

Uses

Used in Organic Synthesis:
Cyclohexylammonium acetate is used as a phase-transfer catalyst for facilitating the synthesis of various organic compounds, particularly in reactions involving quaternary ammonium salts, due to its effectiveness in aiding reactant transfer.
Used in Pharmaceutical Production:
In the pharmaceutical industry, cyclohexylammonium acetate is used as a reagent in the production of pharmaceuticals, contributing to the synthesis of various medicinal compounds.
Used in Agrochemical Production:
Similarly, in the agrochemical sector, cyclohexylammonium acetate is employed as a reagent in the synthesis of agrochemicals, playing a role in the development of products for agricultural applications.
Used in Coatings and Adhesives Formulation:
Cyclohexylammonium acetate is used as a component in the formulation of certain types of coatings and adhesives, enhancing their properties and performance.
Used in Corrosion Inhibition:
In industrial processes, cyclohexylammonium acetate has shown potential as a corrosion inhibitor, helping to protect materials from degradation and extending their service life.

InChI:InChI=1/C6H13N.C2H4O2/c7-6-4-2-1-3-5-6;1-2(3)4/h6H,1-5,7H2;1H3,(H,3,4)

Downstream Products

• 114820-96-1 2-cyclohexyl-oxaziridine 
• 100384-75-6 1-cyclo-hexyl-3-(1,1-dimethylallyl)-thiourea 
• 122641-43-4 2-cyclo-hexylamino-4,5-diphenylthiazole 
• 1185-59-7 tetraethylammonium acetate 
• 23126-79-6 6-chloro-N-cyclohexyl-5-nitropyrimidin-4-amine 

Relevant academic research and scientific papers

NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS

The invention relates to a compound of the formula (I): in which k and j are independently 0 or 1, Y is a macrocycle in which the cycle includes 9 to 36 carbon atoms and is functionalised by three amino functions and by a chain for attaching the spacer arm Z via an X bond, Rc is a binding pattern with a receptor of the TNF superfamily, X is a chemical function for binding the Y group to the space arm, and Z is a bi-, tri- or tetra-functional spacer arm.

NOVEL MULTIMERIC CD40 LIGANDS, METHOD FOR PREPARING SAME AND USE THEREOF FOR PREPARING DRUGS

The invention concerns a compound of formula (I), wherein Y represents a macrocycle whereof the cycle comprises 9 to 36 atoms, and is functionalized by three amine or COOH functions; Rc represents a group of formula H—Xa—Xb—Xc—Xd—Xe—(Xf)i—, wherein i represents 0 or 1, Xn is in particular selected among lysine, arginine, ornithine residues, Xb is in particular selected among glycine, asparagine, L-proline or D-proline residues, Xc et Xd are in particular selected among tyrosine, phenylalanine or 3-nitrotyrosine residues, Xe et Xf are in particular selected among the following amino acid residues: NH2—(CH2)n—COOH, n ranging from 1 to 10 or NH2—(CH2—CH2—O)m—CH2CH2COOH, m ranging from 3 to 6, provided that one at least of the amino acid residues Xa, Xb, Xc and Xd is different from the corresponding amino acid in the sequence of the natural CD40 143Lys-Gly-Tyr-Tyr146 fragment